Patents Represented by Attorney Gale Matthews

Find this attorney in the Justia Lawyer Directory

  • Receptor identification method
    Patent number: 6077666
    Abstract: The present invention relates to a method for isolating and cloning receptor DNA sequences. The invention also provides novel DNA sequences encoding a novel somatostatin receptor subtype.
    Type: Grant
    Filed: May 8, 1997
    Date of Patent: June 20, 2000
    Assignee: American Cyanamid Company
    Inventors: John Richard Hadcock, Bradley Alton Ozenberger, Mark Henry Pausch
  • Method to identify plant proteins that function in G protein coupled systems and compositions therefor
    Patent number: 5985584
    Abstract: The present invention is directed to a method of identifying plant proteins that function as or similar to G protein coupled receptors, or as plant G protein subunits utilizing a bioassay system that incorporates such plant proteins. Further aspects of the present invention provides expression vectors and yeast cells transformed therewith encoding the plant proteins whose identity it is desired to determine, and methods utilizing same.
    Type: Grant
    Filed: February 19, 1997
    Date of Patent: November 16, 1999
    Assignee: American Cyanamid Company
    Inventor: Laura Patricia Sarokin
  • Somatostatin receptor protein
    Patent number: 5929209
    Abstract: The present invention relates to a method for isolating and cloning receptor DNA sequences. The invention also provides novel DNA sequences encoding a novel somatostatin receptor subtype.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: July 27, 1999
    Assignee: American Cyanamid Company
    Inventors: John Richard Hadcock, Bradley Alton Ozenberger, Mark Henry Pausch
  • Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins
    Patent number: 5888513
    Abstract: Recombinant proteins of the causative virus of porcine reproductive and respiratory syndrome (PRRS), corresponding to ORFs 2 to 7 of the PRRSV Spanish isolate (PRRS-Olot), have been produced in baculovirus expression system using Sf9 cell cultures as a permissive host. These recombinant proteins are suitable for the formulation of vaccines capable of efficaciously protecting porcine livestock from PRRS and for the preparation of diagnostic kits adequate for detection of anti-PRRSV antibodies as well as of PRRSV in a pig biological sample. This invention is of interest to Veterinary Medicine.
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: March 30, 1999
    Assignee: Cyanamid Iberica, S.A.
    Inventors: Juan Plana Duran, Jose Ignacio Casal Alvarez, Isabel Climent Sanchez